Comparison of effects of anagliptin and alogliptin on serum lipid profile in type 2 diabetes mellitus patients

INTRODUCTION: Anagliptin (ANA) improves dyslipidemia in addition to blood glucose levels. However, there are no comparative studies on the effects of ANA and other dipeptidyl peptidase‐4 inhibitors on serum lipid profile. We compared the effects of ANA on serum lipid profile with those of alogliptin...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurozumi, Akira, Okada, Yosuke, Arao, Tadashi, Kobayashi, Takuya, Masuda, Daisaku, Yamashita, Shizuya, Tanaka, Yoshiya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835469/
https://www.ncbi.nlm.nih.gov/pubmed/28853228
http://dx.doi.org/10.1111/jdi.12739

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835469/
https://www.ncbi.nlm.nih.gov/pubmed/28853228
http://dx.doi.org/10.1111/jdi.12739

Ejemplares similares